Literature DB >> 12432917

Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2.

Charles D Loftin1, Howard F Tiano, Robert Langenbach.   

Abstract

The development of mice deficient in either cyclooxygenase-1 (COX-1) or COX-2, as well as mice deficient in both COX isoforms, has provided models to elucidate the physiological and pathophysiological roles of these enzymes. The findings obtained with the COX-deficient mice suggest that COX-2 may be more important than COX-1 for supplying prostaglandins (PGs) to maintain tissue homeostasis. Furthermore, both isoforms may be involved in the development of diseases, such as inflammation and cancer. Therefore, the contribution of each isoform to the prevention or development of disease is more complex than originally described. Studies with the COX-deficient mice suggest that in addition to COX-2-selective inhibition, therapeutic advances may also be achieved with COX-1-selective inhibitors which lack gastrointestinal side effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12432917     DOI: 10.1016/s0090-6980(02)00028-x

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  37 in total

1.  Cyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins.

Authors:  Noriyuki Omura; Margaret Griffith; Audrey Vincent; Ang Li; Seung-Mo Hong; Kimberly Walter; Michael Borges; Michael Goggins
Journal:  Mol Cancer Res       Date:  2010-06-08       Impact factor: 5.852

2.  Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice.

Authors:  Xinzhi Li; Liudmila L Mazaleuskaya; Laurel L Ballantyne; Hu Meng; Garret A FitzGerald; Colin D Funk
Journal:  J Lipid Res       Date:  2017-11-27       Impact factor: 5.922

3.  Model-based prediction of the acute and long-term safety profile of naproxen in rats.

Authors:  Tarjinder Sahota; Ian Sanderson; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Pharmacol       Date:  2015-06-29       Impact factor: 8.739

4.  Alterations in eicosanoid composition during embryonic development in the chorioallantoic membrane of the American alligator (Alligator mississippiensis) and domestic chicken (Gallus gallus).

Authors:  Theresa M Cantu; John A Bowden; Jacob Scott; Jimena B Pérez-Viscasillas; Kevin Huncik; Matthew P Guillette; Louis J Guillette
Journal:  Gen Comp Endocrinol       Date:  2016-07-09       Impact factor: 2.822

5.  EP4 receptor regulates collagen type-I, MMP-1, and MMP-3 gene expression in human tendon fibroblasts in response to IL-1 beta treatment.

Authors:  Bhavani P Thampatty; Hongxia Li; Hee-Jeong Im; James H-C Wang
Journal:  Gene       Date:  2006-09-15       Impact factor: 3.688

Review 6.  Pathogenesis of neonatal necrotizing enterocolitis.

Authors:  Joanna C Lim; Jamie M Golden; Henri R Ford
Journal:  Pediatr Surg Int       Date:  2015-04-09       Impact factor: 1.827

7.  Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk.

Authors:  Claudia A Salinas; Erika M Kwon; Liesel M FitzGerald; Ziding Feng; Peter S Nelson; Elaine A Ostrander; Ulrike Peters; Janet L Stanford
Journal:  Am J Epidemiol       Date:  2010-08-05       Impact factor: 4.897

8.  Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesis.

Authors:  Elvira L Liclican; Van Nguyen; Aaron B Sullivan; Karsten Gronert
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-07-07       Impact factor: 4.799

9.  Cyclooxygenase-2 in newborn hyperoxic lung injury.

Authors:  Rodney D Britt; Markus Velten; Trent E Tipple; Leif D Nelin; Lynette K Rogers
Journal:  Free Radic Biol Med       Date:  2013-04-25       Impact factor: 7.376

10.  Growth factor regulation of prostaglandin-endoperoxide synthase 2 (Ptgs2) expression in colonic mesenchymal stem cells.

Authors:  Monica R Walker; Sarah L Brown; Terrence E Riehl; William F Stenson; Thaddeus S Stappenbeck
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.